Deslanatoside C is a pharmaceutical compound that belongs to the cardiac glycoside class. Its name consists of three parts: "des", "lanato-", and "-side C". The first part, "des", means that the compound is a derivative of the lanatoside family. The second part, "lanato-", refers to the source of the compound, which is the plant Digitalis lanata. The last part, "-side C", identifies the specific glycoside. In IPA phonetic transcription, the word is pronounced /dɛzləˈneɪtoʊsaɪd siː/.
Deslanatoside C is a chemical compound that belongs to the group of cardiac glycosides, known for their medicinal properties in treating various cardiovascular conditions. It serves as an active ingredient in certain medications used to manage heart failure and irregular heart rhythms.
The compound can be found naturally in certain plants, such as Digitalis purpurea, commonly known as Foxglove. It is extracted from the leaves of these plants and then processed into a purified form for pharmaceutical use. Deslanatoside C exerts its therapeutic effects by inhibiting the sodium-potassium ATPase enzyme in heart muscle cells, which ultimately enhances cardiac contractility and improves the efficiency of the heart's pumping action.
In medical practice, Deslanatoside C is typically prescribed to patients with congestive heart failure, a condition characterized by the heart's inability to pump blood effectively. By increasing the heart's strength and regulating its rhythm, Deslanatoside C helps alleviate symptoms such as shortness of breath, fatigue, and fluid retention. It may also be used to treat other cardiac conditions, such as certain types of arrhythmias (abnormal heart rhythms).
However, it is important to note that Deslanatoside C should only be used under the supervision of a healthcare professional, as its dosage and administration require careful monitoring. Additionally, potential side effects of Deslanatoside C may include nausea, vomiting, headache, dizziness, and alterations in electrolyte levels.